Canlyniadau Chwilio - Ashwin N. Ananthakrishnan

Mireinio'r Canlyniadau
  1. 1
    Environmental Triggers for Inflammatory Bowel Disease

    Environmental Triggers for Inflammatory Bowel Disease gan Ashwin N. Ananthakrishnan

    Cyhoeddwyd 2012
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis

    Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis gan Ashwin N. Ananthakrishnan

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Environmental Risk Factors for Inflammatory Bowel Diseases: A Review

    Environmental Risk Factors for Inflammatory Bowel Diseases: A Review gan Ashwin N. Ananthakrishnan

    Cyhoeddwyd 2014
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Environmental Hygiene and Risk of Inflammatory Bowel Diseases

    Environmental Hygiene and Risk of Inflammatory Bowel Diseases gan Aurada Cholapranee, Ashwin N. Ananthakrishnan

    Cyhoeddwyd 2016
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Economic burden and cost-effectiveness of therapies for <i>Clostridiodes difficile</i> infection: a narrative review

    Economic burden and cost-effectiveness of therapies for <i>Clostridiodes difficile</i> infection: a narrative review gan Akshita Gupta, Ashwin N. Ananthakrishnan

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Review article: vitamin D and inflammatory bowel diseases

    Review article: vitamin D and inflammatory bowel diseases gan V. Pratap Mouli, Ashwin N. Ananthakrishnan

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis

    Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis gan Nienke Z. Borren, Ashwin N. Ananthakrishnan

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Epidemiology of Primary and Secondary Liver Cancers

    Epidemiology of Primary and Secondary Liver Cancers gan Ashwin N. Ananthakrishnan, Veena Gogineni, Kia Saeian

    Cyhoeddwyd 2006
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases

    Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases gan Ashwin N. Ananthakrishnan, Emily L. McGinley

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Pivot to Asia: inflammatory bowel disease burden

    Pivot to Asia: inflammatory bowel disease burden gan Prashant Singh, Ashwin N. Ananthakrishnan, Vineet Ahuja

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Clostridium difficile and inflammatory bowel disease

    Clostridium difficile and inflammatory bowel disease gan Mazen Issa, Ashwin N. Ananthakrishnan, David G. Binion

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Higher Physician Density is Associated with Lower Incidence of Late-stage Colorectal Cancer

    Higher Physician Density is Associated with Lower Incidence of Late-stage Colorectal Cancer gan Ashwin N. Ananthakrishnan, Raymond G. Hoffmann, Kia Saeian

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Can Mucosal Healing Be a Cost-effective Endpoint for Biologic Therapy in Crohnʼs Disease? A Decision Analysis

    Can Mucosal Healing Be a Cost-effective Endpoint for Biologic Therapy in Crohnʼs Disease? A Decision Analysis gan Ashwin N. Ananthakrishnan, Joshua R. Korzenik, Chin Hur

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Diet in Treatment of Inflammatory Bowel Diseases

    Diet in Treatment of Inflammatory Bowel Diseases gan Alexa N. Sasson, Ashwin N. Ananthakrishnan, Maitreyi Raman

    Cyhoeddwyd 2019
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Outcomes of Weekend Admissions for Upper Gastrointestinal Hemorrhage: A Nationwide Analysis

    Outcomes of Weekend Admissions for Upper Gastrointestinal Hemorrhage: A Nationwide Analysis gan Ashwin N. Ananthakrishnan, Emily L. McGinley, Kia Saeian

    Cyhoeddwyd 2008
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Management of Inflammatory Bowel Disease in the Elderly Patient

    Management of Inflammatory Bowel Disease in the Elderly Patient gan Ashwin N. Ananthakrishnan, Tamara Donaldson, Karen Lasch, Vijay Yajnik

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review

    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review gan Ashwin N. Ananthakrishnan, Geoffrey C. Nguyen, Çharles N. Bernstein

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor α Antagonists in Inflammatory Bowel Diseases

    Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor α Antagonists in Inflammatory Bowel Diseases gan David Cheng, Bharati Kochar, Tianxi Cai, Ashwin N. Ananthakrishnan

    Cyhoeddwyd 2022
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Inflammatory bowel disease in the elderly is associated with worse outcomes: A national study of hospitalizations

    Inflammatory bowel disease in the elderly is associated with worse outcomes: A national study of hospitalizations gan Ashwin N. Ananthakrishnan, Emily L. McGinley, David G. Binion

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact

    The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact gan Nienke Z. Borren, Shadi Ghadermarzi, Susan Hutfless, Ashwin N. Ananthakrishnan

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: